Business Standard

Saturday, December 21, 2024 | 08:28 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

This pharma stock has zoomed 567% in 40 trading days post re-listing

According to latest shareholding pattern data, the company's promoter held 98.04 per cent stake

stocks, india inc, markets, investment, shares, dividends, brokers, shares, company, firms, BSE, exchange, earnings, results, profit, loss, dividend payout, tax
Premium

SI Reporter Mumbai
Shares of Orchid Pharma were locked in upper circuit for the 40th straight trading day, up 5 per cent at Rs 120.13 on the BSE on Wednesday. The stock has zoomed 567 per cent from the level of Rs 18, since its relisting on November 3, 2020.

Till 12:35 pm, a combined only 83 equity shares had changed hands and there were pending buy orders for 135,000 shares on the BSE and NSE, the exchange data shows. In comparison, the S&P BSE Sensex was down 0.28 per cent at 47,478 points.

Currently, Orchid Pharma is trading under T

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in